Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    • News

  • Novatti formalises new fintech incubation project RentPay
    • News

    Novatti formalises new fintech incubation project RentPay

    Fintech company Novatti Group (ASX: NOV) has formalised an agreement to commence re-development of rental payments platform RentPay, in collaboration with Rent.com.au (ASX: RNT), Australia’s leading website dedicated to the rental property market.  The partnership provides Rent.com.au with access to Novatti’s award-winning payment processing technology with Novatti gaining access to the rental payments market.  “Novatti

    Read More
    Public
  • Aeris Active virus killer approved for sale in the UK
    • News

    Aeris Active virus killer approved for sale in the UK

    Environmental biotech company Aeris Environmental (ASX: AEI) has seen no shortage of demand for its Aeris Active disinfectant but is set to capitalise on global demand further with approval from the UK Poison Control Centre for sale in the UK.  With independent labs already confirming that Aeris Active is more than 99.99% effective in deactivating

    Read More
    Public
  • ASX IPO Watch – March Listings:  AML3D, United Malt
    • News

    ASX IPO Watch – March Listings: AML3D, United Malt

    With the international and domestic share market experiencing uncertainty from the implications of coronavirus, it is hardly surprising that panic has not only scared off investors, but companies as well, with only two companies planned to list on the exchange this month. While thedocyard, Emerald Clinics, and Little Green Pharma completing their listings last month

    Read More
    Public
  • Norwood and Spark NZ launch voicemail app, rockets to #6 on charts
    • News

    Norwood and Spark NZ launch voicemail app, rockets to #6 on charts

    Communications tech company Norwood Systems (ASX: NOR) has earmarked a substantial rise in future revenue following the successful launch of their voicemail app with partner Spark NZ (ASX: SPK), the largest telecommunications provider in New Zealand.  The process of rolling out the Spark Voicemail app has been a prompt one, with Norwood and Spark having

    Read More
    Public
  • Forget goat milk, Have you tried oat milk? Wide Open Agri coming to a fridge near you
    • News

    Forget goat milk, Have you tried oat milk? Wide Open Agri coming to a fridge near you

    Regenerative food and farming company, Wide Open Agriculture (ASX: WOA), have announced that they are in the final stages of testing their new oat-milk product. The company is based on the wheatbelt in Western Australia and has 5000L of the plant-based milk ready to commence market testing to trial the milk’s taste and texture with

    Read More
    Public
  • NZ Coastal Seafoods expands facility, production to double
    • News

    NZ Coastal Seafoods expands facility, production to double

    Seafood company New Zealand Coastal Seafoods (ASX: NZS) is set to capitalise on global interest in Kiwi seafood products with the expansion of their Christchurch facility which will enable the company to double its dried seafood production.  The facility is now five times larger than the existing one and located near Christchurch Airport which is

    Read More
    Public
  • New ASX listing Founders First acquires award winning Kangaroo Island Distillery
    • News

    New ASX listing Founders First acquires award winning Kangaroo Island Distillery

    Following the company’s successful $15 million IPO capital raising, Australian craft beverage company Founders First (ASX: FFL) has announced the acquisition of Kangaroo Island Distillery (KIS) for $1.5 million. The company has been busy since listing back in December 2019, with similar sized acquisitions in Hunter Valley and Moonee Ponds, and a significant convertible note

    Read More
    Public
  • Zoono successfully tests against coronavirus COVID-19, shares skyrocket
    • News

    Zoono successfully tests against coronavirus COVID-19, shares skyrocket

    Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

    Read More
    Public
  • Little Green Pharma to supply medicinal cannabis to underserviced German market
    • News

    Little Green Pharma to supply medicinal cannabis to underserviced German market

    Australian medicinal cannabis and healthcare company Little Green Pharma (ASX: LGP) has this morning announced a key purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1000kg of dried cannabis flower or 48,000 units of medicinal cannabis per annum. The agreement makes LGP one of the first few companies to export

    Read More
    Public
  • With trade stalling in China, Eagle Health turns to Africa with new continental distributor
    • News

    With trade stalling in China, Eagle Health turns to Africa with new continental distributor

    As fears over the coronavirus outbreak continue to spread, health and nutritional product manufacturer Eagle Health (ASX: EHH) is set to diversify their distribution channels by entering a collaborative agreement with Amka Products which has a continental footprint throughout Africa.  The agreement will see AMKA, a market leader for manufacturing and distribution of health products

    Read More
    Public
  • «
  • ‹
  • 297
  • 298
  • 299
  • 300
  • 301
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.